http://orcid.org/0000-0002-3713-9570

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2024 | 2022 | 2021

2024

Oechtering, Johanna; Stein, Kerstin; Schaedelin, Sabine A; Maceski, Aleksandra M; Orleth, Annette; Meier, Stephanie; Willemse, Eline; Qureshi, Ferhan; Heijnen, Ingmar; Regeniter, Axel; Derfuss, Tobias; Benkert, Pascal; D'Souza, Marcus; Limberg, Marguerite; Fischer-Barnicol, Bettina; Achtnichts, Lutz; Mueller, Stefanie; Salmen, Anke; Lalive, Patrice H; Bridel, Claire; ... (2024). Complement Activation Is Associated With Disease Severity in Multiple Sclerosis. Neurology: Neuroimmunology and Neuroinflammation, 11(2), e200212. Wolters Kluwer Health 10.1212/NXI.0000000000200212

2022

Achtnichts, Lutz; Ovchinnikov, Arkady; Jakopp, Barbara; Oberle, Michael; Nedeltchev, Krassen; Fux, Christoph Andreas; Sellner, Johann; Findling, Oliver (2022). SARS-CoV-2 mRNA Vaccination in People with Multiple Sclerosis Treated with Fingolimod: Protective Humoral Immune Responses May Develop after the Preferred Third Shot. Vaccines, 10(2) MDPI 10.3390/vaccines10020341

2021

Achtnichts, Lutz; Jakopp, Barbara; Oberle, Michael; Nedeltchev, Krassen; Fux, Christoph Andreas; Sellner, Johann; Findling, Oliver (2021). Humoral Immune Response after the Third SARS-CoV-2 mRNA Vaccination in CD20 Depleted People with Multiple Sclerosis. Vaccines, 9(12) MDPI 10.3390/vaccines9121470

Provide Feedback